Persistent Lyme Empiric Antibiotic Study Europe

NCT01207739 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Lyme Disease
Borrelia Infection

Interventions

DRUG: Doxycycline
DRUG: Clarithromycin and hydroxychloroquine
DRUG: Placebo

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]